Trial on Single/Multiple Ascending Doses for Safety, PK and PD for CBP-0276 in Healthy Subjects

NCT07708831 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: CBP-0276 Acetate
DRUG: Placebo for CBP-0276 Acetate

Sponsor

Clarent Biopharma, Inc.